Literature DB >> 23970793

Clinical significance of androgen receptor and its phosphorylated form in breast cancer.

Takashi Takeshita, Yoko Omoto, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Hirotaka Iwase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23970793     DOI： 10.1530/ERC-13-0317

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  7 in total

1.  Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.

Authors:  Roshan Sriram; Vivian Lo; Benjamin Pryce; Lilia Antonova; Alan J Mears; Manijeh Daneshmand; Bruce McKay; Simon J Conway; William J Muller; Luc A Sabourin
Journal:  Breast Cancer Res       Date:  2015-01-16       Impact factor: 6.466

2.  Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer.

Authors:  Takashi Takeshita; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Toko Inao; Aiko Sueta; Saori Fujiwara; Yoko Omoto; Hirotaka Iwase
Journal:  Cancer Sci       Date:  2015-10-30       Impact factor: 6.716

3.  Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients.

Authors:  Takashi Takeshita; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Aiko Sueta; Mai Tomiguchi; Keiichi Murakami; Yoko Omoto; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2017-11-22       Impact factor: 4.430

4.  Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients.

Authors:  Takashi Takeshita; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Mai Tomiguchi; Aiko Sueta; Keiichi Murakami; Yoko Omoto; Hirotaka Iwase
Journal:  Transl Oncol       Date:  2017-08-01       Impact factor: 4.243

5.  Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.

Authors:  Takashi Takeshita; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Toko Inao; Aiko Sueta; Saori Fujiwara; Yoko Omoto; Hirotaka Iwase
Journal:  Oncotarget       Date:  2016-05-31

6.  Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.

Authors:  Takashi Takeshita; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Mai Tomiguchi; Aiko Sueta; Keiichi Murakami; Yoko Omoto; Hirotaka Iwase
Journal:  Oncotarget       Date:  2017-06-14

7.  Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.

Authors:  Khalid N Al-Zahrani; David P Cook; Barbara C Vanderhyden; Luc A Sabourin
Journal:  Oncotarget       Date:  2018-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.